491 related articles for article (PubMed ID: 31992854)
1. The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome.
D'Arcangelo E; Wu NC; Cadavid JL; McGuigan AP
Br J Cancer; 2020 Mar; 122(7):931-942. PubMed ID: 31992854
[TBL] [Abstract][Full Text] [Related]
2. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
3. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma.
Luo W; Zhang T
Cancer Lett; 2023 Jul; 567():216279. PubMed ID: 37336287
[TBL] [Abstract][Full Text] [Related]
6. Portrait of a CAF: The story of cancer-associated fibroblasts in head and neck cancer.
Custódio M; Biddle A; Tavassoli M
Oral Oncol; 2020 Nov; 110():104972. PubMed ID: 33011636
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
Caramelo B; Zagorac S; Corral S; Marqués M; Real FX
Eur Urol Oncol; 2023 Aug; 6(4):366-375. PubMed ID: 36890105
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
9. Cancer associated fibroblasts: is the force the path to the dark side?
Barbazán J; Matic Vignjevic D
Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martinez-Zubiaurre I; Hellevik T
Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
12. Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer.
Chen Y; Liang Z; Lai M
Transl Res; 2024 Aug; 270():81-93. PubMed ID: 38614213
[TBL] [Abstract][Full Text] [Related]
13. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
Sazeides C; Le A
Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
[TBL] [Abstract][Full Text] [Related]
15. CAF-immune cell crosstalk and its impact in immunotherapy.
Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
[TBL] [Abstract][Full Text] [Related]
16. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts: Secretions, interactions, and therapy.
Farhood B; Najafi M; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2791-2800. PubMed ID: 30260049
[TBL] [Abstract][Full Text] [Related]
18. Turning foes to friends: targeting cancer-associated fibroblasts.
Chen X; Song E
Nat Rev Drug Discov; 2019 Feb; 18(2):99-115. PubMed ID: 30470818
[TBL] [Abstract][Full Text] [Related]
19. Clinical and therapeutic relevance of cancer-associated fibroblasts.
Chen Y; McAndrews KM; Kalluri R
Nat Rev Clin Oncol; 2021 Dec; 18(12):792-804. PubMed ID: 34489603
[TBL] [Abstract][Full Text] [Related]
20. Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity.
Koppensteiner L; Mathieson L; O'Connor RA; Akram AR
Front Immunol; 2022; 13():887380. PubMed ID: 35479076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
